These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25539849)

  • 21. Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.
    Rossi G; Papotti M; Barbareschi M; Graziano P; Pelosi G
    J Clin Oncol; 2009 Oct; 27(28):e141-2; author reply e143-4. PubMed ID: 19720885
    [No Abstract]   [Full Text] [Related]  

  • 22. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing dynamic regulatory programs in mouse lung development and their potential association with tumourigenesis via miRNA-TF-mRNA circuits.
    Liu J; Ye X; Wu FX
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S11. PubMed ID: 24564886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types.
    Li R; Jiang S; Li W; Hong H; Zhao C; Huang X; Zhang Z; Li H; Chen H; Bo X
    RNA Biol; 2019 Aug; 16(8):1010-1021. PubMed ID: 31046554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review).
    Liang X; Wu Q; Wang Y; Li S
    Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.
    Barh D; Jain N; Tiwari S; Field JK; Padin-Iruegas E; Ruibal A; López R; Herranz M; Bhattacharya A; Juneja L; Viero C; Silva A; Miyoshi A; Kumar A; Blum K; Azevedo V; Ghosh P; Liloglou T
    BMC Genomics; 2013; 14 Suppl 6(Suppl 6):S5. PubMed ID: 24564251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of lung cancer miRNA-miRNA co-regulation networks through a progressive data refining approach.
    Song R; Catchpoole DR; Kennedy PJ; Li J
    J Theor Biol; 2015 Sep; 380():271-9. PubMed ID: 26026830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of microRNAs and their target genes in non-small-cell lung cancer.
    Lee HY; Han SS; Rhee H; Park JH; Lee JS; Oh YM; Choi SS; Shin SH; Kim WJ
    Mol Med Rep; 2015 Mar; 11(3):2034-40. PubMed ID: 25376560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions.
    Zhao N; Liu Y; Chang Z; Li K; Zhang R; Zhou Y; Qiu F; Han X; Xu Y
    PLoS One; 2015; 10(9):e0139165. PubMed ID: 26402252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma.
    Liu H; Li T; Dong C; Lyu J
    PLoS One; 2022; 17(3):e0264645. PubMed ID: 35290415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
    J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic immune markers in non-small cell lung cancer.
    Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
    Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MicroRNAs--new biomarkers of respiratory tract diseases].
    Kupczyk M; Kuna P
    Pneumonol Alergol Pol; 2014; 82(2):183-90. PubMed ID: 24615202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation analysis reveals dysfunctional regulatory mechanism involving transcription factors and microRNAs in gastric carcinogenesis.
    Li Q; Li J; Dai W; Li YX; Li YY
    Artif Intell Med; 2017 Mar; 77():12-22. PubMed ID: 28545608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.